Found: 32
Select item for more details and to access through your institution.
Converging evidence of impaired brain function in systemic lupus erythematosus: changes in perfusion dynamics and intrinsic functional connectivity.
- Published in:
- Neuroradiology, 2022, v. 64, n. 8, p. 1593, doi. 10.1007/s00234-022-02924-x
- By:
- Publication type:
- Article
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 01, doi. 10.3389/fimmu.2022.1074044
- By:
- Publication type:
- Article
Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.860726
- By:
- Publication type:
- Article
Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the "Attikon" Lupus Cohort.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.889613
- By:
- Publication type:
- Article
Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: a systematic literature review of individual patients' data.
- Published in:
- Turkish Journal of Medical Sciences, 2020, v. 50, n. 2, p. 281, doi. 10.3906/sag-1910-39
- By:
- Publication type:
- Article
The relation of partners' illness representations to the coping behaviors of patients with inflammatory rheumatic diseases through patients' illness representation: A dyadic regulation process.
- Published in:
- Current Psychology, 2023, v. 42, n. 20, p. 16923, doi. 10.1007/s12144-022-02937-y
- By:
- Publication type:
- Article
Paraneoplastic digital ischemia in clear-cell renal-cell carcinoma: Report of a case and review of the literature.
- Published in:
- Urologia Journal, 2019, v. 86, n. 3, p. 156, doi. 10.1177/0391560318761289
- By:
- Publication type:
- Article
Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association?
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy.
- Published in:
- BMC Genomics, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12864-023-09275-8
- By:
- Publication type:
- Article
Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective study.
- Published in:
- Rheumatology, 2024, v. 63, n. 10, p. 2711, doi. 10.1093/rheumatology/keae119
- By:
- Publication type:
- Article
Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease.
- Published in:
- Rheumatology, 2022, v. 61, n. 9, p. 3606, doi. 10.1093/rheumatology/keac005
- By:
- Publication type:
- Article
Diffuse oesophageal involvement in anti-NXP2 myositis and response to combined immunosuppressive therapy.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Demyelination with autoimmune features: a distinct clinical entity? Results from a longitudinal cohort.
- Published in:
- Rheumatology, 2021, v. 60, n. 9, p. 4166, doi. 10.1093/rheumatology/keaa902
- By:
- Publication type:
- Article
Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres.
- Published in:
- Rheumatology, 2015, v. 54, n. 7, p. 1270, doi. 10.1093/rheumatology/keu482
- By:
- Publication type:
- Article
Control of flares and relief of urate burden with canakinumab and targeted urate-lowering therapy in tophaceous gouty arthritis.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Control of flares and relief of urate burden with canakinumab and targeted urate-lowering therapy in tophaceous gouty arthritis.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Hepatitis B reactivation following treatment with abatacept in a patient with past hepatitis B virus infection.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Hepatitis B reactivation following treatment with abatacept in a patient with past hepatitis B virus infection.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Systemic Lupus Erythematosus and COVID-19.
- Published in:
- Current Rheumatology Reports, 2023, v. 25, n. 10, p. 192, doi. 10.1007/s11926-023-01110-z
- By:
- Publication type:
- Article
Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Mediterranean diet and exercise are associated with better disease control in psoriatic arthritis.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 9, p. 2877, doi. 10.1007/s10067-024-07080-6
- By:
- Publication type:
- Article
Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 8, p. 898, doi. 10.3390/cells8080898
- By:
- Publication type:
- Article
Tailored treatment strategies and future directions in systemic lupus erythematosus.
- Published in:
- Rheumatology International, 2022, v. 42, n. 8, p. 1307, doi. 10.1007/s00296-022-05133-0
- By:
- Publication type:
- Article
Recent progress in the treatment of lupus nephritis.
- Published in:
- Modern Rheumatology, 2012, v. 22, n. 6, p. 803, doi. 10.3109/s10165-012-0655-4
- By:
- Publication type:
- Article
Evolving Concepts in Systemic Lupus Erythematosus.
- Published in:
- Israel Medical Association Journal, 2016, v. 18, n. 12, p. 683
- By:
- Publication type:
- Article
Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients.
- Published in:
- Lupus, 2024, v. 33, n. 11, p. 1248, doi. 10.1177/09612033241273023
- By:
- Publication type:
- Article
Multidisciplinary approach to lupus nephritis: Clinical pearls, pitfalls, and positioning of newly-approved agents.
- Published in:
- Lupus, 2023, v. 32, n. 10, p. 1155, doi. 10.1177/09612033231191944
- By:
- Publication type:
- Article
Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study.
- Published in:
- Lupus, 2023, v. 32, n. 2, p. 225, doi. 10.1177/09612033221144425
- By:
- Publication type:
- Article
Residual disease activity and treatment intensification in systemic lupus erythematosus: A cross-sectional study to quantify the need for new therapies.
- Published in:
- Lupus, 2022, v. 31, n. 14, p. 1726, doi. 10.1177/09612033221129776
- By:
- Publication type:
- Article
Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
- Published in:
- Lupus, 2021, v. 30, n. 14, p. 2237, doi. 10.1177/09612033211061062
- By:
- Publication type:
- Article
Targeted Biologic Therapy for Systemic Lupus Erythematosus: Emerging Pathways and Drug Pipeline.
- Published in:
- BioDrugs, 2020, v. 34, n. 2, p. 133, doi. 10.1007/s40259-020-00405-2
- By:
- Publication type:
- Article